A participant in a landmark clinical trial has been given a cellular-reprogramming treatment that aims to rejuvenate damaged ...
First human receives reverse-aging gene therapy in groundbreaking trial targeting glaucoma, using cellular reprogramming to ...
Cellular reprogramming is the hottest topic in longevity science, with tech titans like Sam Altman investing in it. It's now ...
The experimental treatment, known as ER-100, is being tested in patients suffering from glaucoma and other forms of ...
Life Biosciences says it just dosed its first patient in an FDA-approved clinical trial to reverse age-related blindness.
Image: CC] On Tuesday, Boston-based biotech startup Life Biosciences announced the dosing of its first patient with a cellular reprogramming injection, designed to reverse age-re ...
NewLimit Series C raises $435M led by Founders Fund as Armstrong-backed startup moves epigenetic therapies toward human ...
'30 years of research came down to one moment.' ...
The American biotechnology company Life Biosciences announced last week that it has administered the first experimental treatment ER-100 to a patient suffering from glaucoma, one of the main causes of ...